Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria.
about
Pharmacological management of essential thrombocythemia.The European LeukemiaNet: achievements and perspectives.Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms.Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohortAllogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemiaRevised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study.Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.BCR-ABL1-negative chronic myeloid neoplasms: an update on management techniques.Therapeutic options for patients with polycythemia vera and essential thrombocythemia refractory/resistant to hydroxyurea.Target hematologic values in the management of essential thrombocythemia and polycythemia vera.Is there a role for JAK inhibitors in BCR-ABL1-negative myeloproliferative neoplasms other than myelofibrosis?Approach to patients with essential thrombocythaemia and very high platelet counts: what is the evidence for treatment?Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide.SOHO State-of-the-Art Update and Next Questions: MPN.
P2860
Q34344384-FB6CE5CC-64B3-4780-8D93-2835316A6A60Q34451619-D5A1E511-9A73-41D8-A717-BCA2D9334175Q35433425-754B5B08-FCA8-425C-85AC-C32B18DBC118Q36316145-0BB4EBD8-D5A4-4EFF-88AE-0534AEB3EEDDQ36404698-05367838-F3D5-407D-8D44-5B3A9DD16707Q36907860-DB1E83B3-1201-4A6F-8106-34BFB9CA1E7CQ37676280-09933C04-B04F-4200-BD14-A6E041363E26Q37679175-F0FDCC45-B6CD-4497-B2F5-A8C48D155FACQ38014534-7B5EC204-7FDD-4F74-A54B-163EDABF10BCQ38187684-82ABC3E0-8FD9-45B2-A4CA-6B614E8F0F93Q38210664-092F7865-8E95-4D43-BEDD-DBC3D1F4A8EFQ38292400-A01A7FE6-C822-460E-9749-9F91E7741991Q39041471-852F898E-5A52-473D-9E35-4EF30780C895Q45358890-1F1E91A9-D34A-4DC4-8280-54D5DC51A579Q49580473-4C0C238D-C46C-45EC-BD5E-859B7F136FCA
P2860
Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Hydroxyurea in essential throm ...... European LeukemiaNet criteria.
@en
Hydroxyurea in essential throm ...... European LeukemiaNet criteria.
@nl
type
label
Hydroxyurea in essential throm ...... European LeukemiaNet criteria.
@en
Hydroxyurea in essential throm ...... European LeukemiaNet criteria.
@nl
prefLabel
Hydroxyurea in essential throm ...... European LeukemiaNet criteria.
@en
Hydroxyurea in essential throm ...... European LeukemiaNet criteria.
@nl
P2093
P1433
P1476
Hydroxyurea in essential throm ...... European LeukemiaNet criteria.
@en
P2093
Alessandra Carobbio
Alessandro M Vannucchi
Alessandro Rambaldi
Elisabetta Antonioli
Federica Delaini
Francesco Rodeghiero
Giovanni Barosi
Guido Finazzi
Marco Ruggeri
Tiziano Barbui
P304
P356
10.1182/BLOOD-2010-03-272179
P407
P577
2010-05-17T00:00:00Z